Use of a biomimetic hydrogel depot technology for sustained delivery of GLP-1 receptor agonists reduces burden of diabetes management.
d'Aquino AI, Maikawa CL, Nguyen LT, Lu K, Hall IA, Jons CK, Kasse CM, Yan J, Prossnitz AN, Chang E, Baker SW, Hovgaard L, Steensgaard DB, Andersen HB, Simonsen L, Appel EA.
d'Aquino AI, et al. Among authors: nguyen lt.
Cell Rep Med. 2023 Nov 21;4(11):101292. doi: 10.1016/j.xcrm.2023.101292.
Cell Rep Med. 2023.
PMID: 37992687
Free PMC article.